Article Text

LONG-TERM RESULTS AND PROGNOSTIC ANALYSES IN RECURRENT/REFRACTORY EPITHELIAL OVARIAN CANCER (RREOC) TREATED BY HIGH-DOSE CHEMOTHERAPY (HDC) WITH AUTOLOGOUS STEM CELL SUPPORT (ASCS)

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.